Key result
ECMO successfully bridges a 33-month-old with severe catecholamine-induced cardiomyopathy to recovery.
Why the study?
Does ECMO improve outcomes as a bridge to recovery in pediatric patients with catecholamine-induced cardiomyopathy associated with neuroblastoma?
Case Report (n=1)
Does ECMO improve outcomes as a bridge to recovery in pediatric patients with catecholamine-induced cardiomyopathy associated with neuroblastoma?
ECMO can serve as an effective bridge to recovery in rare cases of severe catecholamine-induced cardiomyopathy associated with neuroblastoma in pediatric patients.
Answers are grounded in this paper and cite their sources.
Supports ECMO bridge in rare pediatric catecholamine cardiomyopathy; leaves open generalizability pending larger studies.
Catecholamine-induced cardiomyopathy associated with neuroblastoma is rarely reported.We report a case of catecholamineinduced cardiomyopathy associated with neuroblastoma in a 33-month-old female that was treated with extracorporeal membrane oxygenation (ECMO).She was tentatively diagnosed with acute myocarditis and presented with hypertension.Because of rapid patient deterioration despite pharmacological treatments, ECMO was applied.ECMO can be helpful in cases of catecholamine-induced cardiomyopathy associated with neuroblastoma.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2015) conducted a case report in Catecholamine-induced cardiomyopathy associated with neuroblastoma (n=1). Extracorporeal Membrane Oxygenation (ECMO) was evaluated on Patient recovery. Extracorporeal membrane oxygenation successfully served as a bridge to recovery for a 33-month-old female with severe catecholamine-induced cardiomyopathy associated with neuroblastoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: